{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:28:24Z","timestamp":1794655704231,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acinar-to-ductal metaplasia (ADM) is a reversible cell state that facilitates pancreas repair following injury. Oncogenic\n                    <jats:italic>KRAS<\/jats:italic>\n                    mutations can progress ADM to pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC). However, the metabolic alterations in these precancerous lesions are understudied. Here, we identify global changes in central carbon metabolism genes and metabolites during ADM formation. In particular, NRF2-target genes are significantly induced in ADM. Among these, we focus on genes encoding NADPH-producing enzymes glucose-6-phosphate dehydrogenase (G6PD) and malic enzyme 1 (ME1), which participate in the regulation of oxidative stress. In mouse models of pancreatic tumourigenesis, G6PD deficiency or\n                    <jats:italic>Me1<\/jats:italic>\n                    loss increases reactive oxygen species and lipid peroxidation, which is accompanied by accelerated formation of ADM and PanIN lesions. Notably,\n                    <jats:italic>Me1<\/jats:italic>\n                    loss, but not G6PD deficiency, promotes faster PDAC progression. We demonstrate that oxidative stress is required for ADM, as pharmacological antioxidant treatment attenuates ADM progression in vivo and ex vivo. Conversely, depleting the antioxidant glutathione promotes precancerous lesions in primary human acinar cells and in mice. Together, our findings shed light on metabolic reprogramming in the precancerous pancreas.\n                  <\/jats:p>","DOI":"10.1038\/s42255-026-01496-x","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:03:32Z","timestamp":1775034212000},"page":"824-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions"],"prefix":"10.1038","volume":"8","author":[{"given":"Megan D.","family":"Radyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8282-4454","authenticated-orcid":false,"given":"Mariana Tannus","family":"Ruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Halbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrou","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-0993","authenticated-orcid":false,"given":"Jonathan M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke L.","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Buscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sajjakulnukit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Corfas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Bednar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pasca di Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-4569","authenticated-orcid":false,"given":"Justin A.","family":"Colacino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2487-4816","authenticated-orcid":false,"given":"Yatrik M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-3019","authenticated-orcid":false,"given":"Howard C.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-6141","authenticated-orcid":false,"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1541-7786.MCR-08-0206","volume":"7","author":"C Shi","year":"2009","unstructured":"Shi, C. et al. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol. Cancer Res. 7, 230\u2013236 (2009).","journal-title":"Mol. Cancer Res."},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M. & Maitra, A. Pancreatic cancer: advances and challenges. Cell 186, 1729\u20131754 (2023).","journal-title":"Cell"},{"key":"1496_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrgastro.2017.12","volume":"14","author":"P Storz","year":"2017","unstructured":"Storz, P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 14, 296\u2013304 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"dmm033373","DOI":"10.1242\/dmm.033373","volume":"11","author":"J Burclaff","year":"2018","unstructured":"Burclaff, J. & Mills, J. C. Plasticity of differentiated cells in wound repair and tumorigenesis, part I: stomach and pancreas. Dis. Model. Mech. 11, dmm033373 (2018).","journal-title":"Dis. Model. Mech."},{"key":"1496_CR5","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.aaa7540","volume":"8","author":"JC Mills","year":"2015","unstructured":"Mills, J. C. & Sansom, O. J. Reserve stem cells: differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract. Sci. Signal. 8, re8 (2015).","journal-title":"Sci. Signal."},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0013","volume":"13","author":"ES Carpenter","year":"2023","unstructured":"Carpenter, E. S. et al. Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions. Cancer Discov. 13, 1324\u20131345 (2023).","journal-title":"Cancer Discov."},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-024-07359-3","volume":"629","author":"AM Braxton","year":"2024","unstructured":"Braxton, A. M. et al. 3D genomic mapping reveals multifocality of human pancreatic precancers. Nature 629, 679\u2013687 (2024).","journal-title":"Nature"},{"key":"1496_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/2159-8290.CD-23-1550","volume":"14","author":"MM Stangis","year":"2024","unstructured":"Stangis, M. M. et al. The hallmarks of precancer. Cancer Discov. 14, 683\u2013689 (2024).","journal-title":"Cancer Discov."},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"1496_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","volume":"31","author":"CJ Halbrook","year":"2017","unstructured":"Halbrook, C. J. & Lyssiotis, C. A. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer. Cancer Cell 31, 5\u201319 (2017).","journal-title":"Cancer Cell"},{"key":"1496_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-021-00375-9","volume":"21","author":"SA Kerk","year":"2021","unstructured":"Kerk, S. A., Papagiannakopoulos, T., Shah, Y. M. & Lyssiotis, C. A. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment. Nat. Rev. Cancer 21, 510\u2013525 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1496_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola, G. M. et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106\u2013109 (2011).","journal-title":"Nature"},{"key":"1496_CR13","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1016\/j.celrep.2016.02.029","volume":"14","author":"GY Liou","year":"2016","unstructured":"Liou, G. Y. et al. Mutant KRas-induced mitochondrial oxidative stress in acinar cells upregulates EGFR signaling to drive formation of pancreatic precancerous lesions. Cell Rep. 14, 2325\u20132336 (2016).","journal-title":"Cell Rep."},{"key":"1496_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2019.12.012","volume":"37","author":"EC Cheung","year":"2020","unstructured":"Cheung, E. C. et al. Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer. Cancer Cell 37, 168\u2013182.e4 (2020).","journal-title":"Cancer Cell"},{"key":"1496_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s43018-025-01003-3","volume":"6","author":"L Antonucci","year":"2025","unstructured":"Antonucci, L. et al. Self-amplifying NRF2\u2013EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer. Nat. Cancer 6, 1263\u20131282 (2025).","journal-title":"Nat. Cancer"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-22-3848","volume":"83","author":"JM DeBlasi","year":"2023","unstructured":"DeBlasi, J. M. et al. Distinct Nrf2 signaling thresholds mediate lung tumor initiation and progression. Cancer Res. 83, 1953\u20131967 (2023).","journal-title":"Cancer Res."},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"103653","DOI":"10.1016\/j.redox.2025.103653","volume":"83","author":"AM Sherwood","year":"2025","unstructured":"Sherwood, A. M., Yasseen, B. A., DeBlasi, J. M., Caldwell, S. & DeNicola, G. M. Distinct roles for the thioredoxin and glutathione antioxidant systems in Nrf2-mediated lung tumor initiation and progression. Redox Biol. 83, 103653 (2025).","journal-title":"Redox Biol."},{"key":"1496_CR18","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1158\/0008-5472.CAN-23-2213","volume":"84","author":"T Neuss","year":"2024","unstructured":"Neuss, T. et al. Metabolic reprogramming is an initial step in pancreatic carcinogenesis that can be targeted to inhibit acinar-to-ductal metaplasia. Cancer Res. 84, 2297\u20132312 (2024).","journal-title":"Cancer Res."},{"key":"1496_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa, T., Ralser, M., Fan, J. & Rabinowitz, J. D. The pentose phosphate pathway in health and disease. Nat. Metab. 5, 1275\u20131289 (2023).","journal-title":"Nat. Metab."},{"key":"1496_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1182\/blood-2007-04-077412","volume":"111","author":"E Beutler","year":"2008","unstructured":"Beutler, E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111, 16\u201324 (2008).","journal-title":"Blood"},{"key":"1496_CR21","unstructured":"Mak, G.K. & Shah, M. Glucose-6-phosphate dehydrogenase deficiency. StatPearls https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470315 (2026)."},{"key":"1496_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying, H. et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656\u2013670 (2012).","journal-title":"Cell"},{"key":"1496_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101\u2013105 (2013).","journal-title":"Nature"},{"key":"1496_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07472-8","volume":"9","author":"N Santana-Codina","year":"2018","unstructured":"Santana-Codina, N. et al. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat. Commun. 9, 4945 (2018).","journal-title":"Nat. Commun."},{"key":"1496_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-019-0202-2","volume":"8","author":"BS Nelson","year":"2020","unstructured":"Nelson, B. S. et al. Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy. Cancer Metab. 8, 1 (2020).","journal-title":"Cancer Metab."},{"key":"1496_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1496_CR28","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"1496_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","volume":"166","author":"IIC Chio","year":"2016","unstructured":"Chio, I. I. C. et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 166, 963\u2013976 (2016).","journal-title":"Cell"},{"key":"1496_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ccell.2017.10.011","volume":"32","author":"J Todoric","year":"2017","unstructured":"Todoric, J. et al. Stress-activated NRF2\u2013MDM2 cascade controls neoplastic progression in pancreas. Cancer Cell 32, 824\u2013839.e8 (2017).","journal-title":"Cancer Cell"},{"key":"1496_CR31","doi-asserted-by":"publisher","unstructured":"Lyssiotis, C. Dataset of gene counts and RPKM from RNA-sequencing of KrasG12D-induced acinar-to-ductal metaplasia in primary mouse pancreas cells [Data set]. Deep Blue Data https:\/\/doi.org\/10.7302\/nd65-zg69 (2025).","DOI":"10.7302\/nd65-zg69"},{"key":"1496_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00555491","volume":"26","author":"W Pretsch","year":"1988","unstructured":"Pretsch, W., Charles, D. J. & Merkle, S. X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem. Genet. 26, 89\u2013103 (1988).","journal-title":"Biochem. Genet."},{"key":"1496_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1096\/fasebj.14.1.111","volume":"14","author":"CJ Nicol","year":"2000","unstructured":"Nicol, C. J., Zielenski, J., Tsui, L. C. & Wells, P. G. An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J. 14, 111\u2013127 (2000).","journal-title":"FASEB J."},{"key":"1496_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469\u2013483 (2005).","journal-title":"Cancer Cell"},{"key":"1496_CR35","doi-asserted-by":"publisher","first-page":"e0303577","DOI":"10.1371\/journal.pone.0303577","volume":"19","author":"JM Alektiar","year":"2024","unstructured":"Alektiar, J. M. et al. Malic enzyme 1 knockout has no deleterious phenotype and is favored in the male germline under standard laboratory conditions. PLoS ONE 19, e0303577 (2024).","journal-title":"PLoS ONE"},{"key":"1496_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cmet.2019.07.003","volume":"30","author":"AMY Zhang","year":"2019","unstructured":"Zhang, A. M. Y. et al. Endogenous hyperinsulinemia contributes to pancreatic cancer development. Cell Metab. 30, 403\u2013404 (2019).","journal-title":"Cell Metab."},{"key":"1496_CR37","doi-asserted-by":"crossref","unstructured":"Zhang, A. M. Y. et al. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 35, 2119\u20132135.e5 (2023).","DOI":"10.1016\/j.cmet.2023.10.003"},{"key":"1496_CR38","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1096\/fj.09-136572","volume":"24","author":"Z Zhang","year":"2010","unstructured":"Zhang, Z. et al. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J. 24, 1497\u20131505 (2010).","journal-title":"FASEB J."},{"key":"1496_CR39","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1074\/jbc.M110.187369","volume":"286","author":"R Szmola","year":"2011","unstructured":"Szmola, R. et al. Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2. J. Biol. Chem. 286, 1819\u20131827 (2011).","journal-title":"J. Biol. Chem."},{"key":"1496_CR40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.gastha.2023.02.003","volume":"2","author":"J Jiang","year":"2023","unstructured":"Jiang, J. et al. Transcriptional profile of human pancreatic acinar ductal metaplasia. Gastro Hep Adv. 2, 532\u2013543 (2023).","journal-title":"Gastro Hep Adv."},{"key":"1496_CR41","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1242\/dev.01925","volume":"132","author":"AL Means","year":"2005","unstructured":"Means, A. L. et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132, 3767\u20133776 (2005).","journal-title":"Development"},{"key":"1496_CR42","doi-asserted-by":"crossref","unstructured":"Doppler, H. R., Liou, G. Y. & Storz, P. Generation of hydrogen peroxide and downstream protein kinase D1 signaling is a common feature of inducers of pancreatic acinar-to-ductal metaplasia. Antioxidants (Basel) 11, 137 (2022).","DOI":"10.3390\/antiox11010137"},{"key":"1496_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/14737140.2017.1261017","volume":"17","author":"N Durand","year":"2017","unstructured":"Durand, N. & Storz, P. Targeting reactive oxygen species in development and progression of pancreatic cancer. Expert Rev. Anticancer Ther. 17, 19\u201331 (2017).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"1496_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02518-0","volume":"24","author":"AK Fleming Martinez","year":"2025","unstructured":"Fleming Martinez, A. K. et al. Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma. Mol. Cancer 24, 300 (2025).","journal-title":"Mol. Cancer"},{"key":"1496_CR45","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.ajpath.2013.02.034","volume":"182","author":"T Al Saati","year":"2013","unstructured":"Al Saati, T. et al. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas. Am. J. Pathol. 182, 1996\u20132004 (2013).","journal-title":"Am. J. Pathol."},{"key":"1496_CR46","doi-asserted-by":"publisher","unstructured":"Hennequart, M. et al. ALDH1L2 regulates reactive oxygen species and acinar-to-ductal metaplasia in the pancreas. Nat. Metab. https:\/\/doi.org\/10.1038\/s42255-026-01456-5 (2026).","DOI":"10.1038\/s42255-026-01456-5"},{"key":"1496_CR47","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/jnci\/88.21.1560","volume":"88","author":"D Albanes","year":"1996","unstructured":"Albanes, D. et al. \u03b1-Tocopherol and \u03b2-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J. Natl Cancer Inst. 88, 1560\u20131570 (1996).","journal-title":"J. Natl Cancer Inst."},{"key":"1496_CR48","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/jnci\/djh320","volume":"96","author":"GE Goodman","year":"2004","unstructured":"Goodman, G. E. et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping \u03b2-carotene and retinol supplements. J. Natl Cancer Inst. 96, 1743\u20131750 (2004).","journal-title":"J. Natl Cancer Inst."},{"key":"1496_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ydbio.2011.11.010","volume":"362","author":"D Kopinke","year":"2012","unstructured":"Kopinke, D. et al. Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. Dev. Biol. 362, 57\u201364 (2012).","journal-title":"Dev. Biol."},{"key":"1496_CR50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone, A. et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 90, 927\u2013963 (2015).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"1496_CR51","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"1496_CR52","doi-asserted-by":"publisher","first-page":"13943","DOI":"10.1073\/pnas.93.24.13943","volume":"93","author":"K Chan","year":"1996","unstructured":"Chan, K., Lu, R., Chang, J. C. & Kan, Y. W. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl Acad. Sci. USA 93, 13943\u201313948 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1496_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2131\/jts.28.455","volume":"28","author":"T Watanabe","year":"2003","unstructured":"Watanabe, T. et al. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine. J. Toxicol. Sci. 28, 455\u2013469 (2003).","journal-title":"J. Toxicol. Sci."},{"key":"1496_CR54","first-page":"e59096","volume":"144","author":"AK Fleming Martinez","year":"2019","unstructured":"Fleming Martinez, A. K. & Storz, P. Mimicking and manipulating pancreatic acinar-to-ductal metaplasia in 3-dimensional cell culture. J. Vis. Exp. 144, e59096 (2019).","journal-title":"J. Vis. Exp."},{"key":"1496_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"1496_CR56","doi-asserted-by":"publisher","unstructured":"Korotkevich, G et al. Fast gene set enrichment analysis. Preprint at https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"1496_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1496_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"1496_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1564-8","volume":"15","author":"HJ Lee","year":"2019","unstructured":"Lee, H. J., Kremer, D. M., Sajjakulnukit, P., Zhang, L. & Lyssiotis, C. A. A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics. Metabolomics 15, 103 (2019).","journal-title":"Metabolomics"},{"key":"1496_CR60","doi-asserted-by":"publisher","first-page":"e73245","DOI":"10.7554\/eLife.73245","volume":"11","author":"SA Kerk","year":"2022","unstructured":"Kerk, S. A. et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Elife 11, e73245 (2022).","journal-title":"Elife"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01496-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:03:00Z","timestamp":1777327380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01496-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01496-x","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the past 3\u2009years, C.A.L. has consulted for Astellas Pharmaceuticals, Odyssey Therapeutics, Third Rock Ventures and T-Knife Therapeutics and is an inventor on patents pertaining to Kras-regulated metabolic pathways, redox control pathways in pancreatic cancer and targeting the GOT1\u2013ME1 pathway as a therapeutic approach (US Patent No. 2015126580-A1, 05\/07\/2015; US Patent No. 20190136238, 05\/09\/2019; International Patent No. WO2013177426-A2, 04\/23\/2015). G.C. was the scientific founder of Decibel Therapeutics, had equity interest in the company and received compensation for consulting. The company was not involved in this study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}